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Abstract
Background Bariatric surgery particularly benefits patients
with obesity-related comorbidities such as type 2 diabetes
and obstructive sleep apnea. We aimed to examine whether
the variables that influence treatment choice differ between
morbidly obese patients undergoing bariatric surgery and
those opting for conservative treatments.
Methods A total of 505 consecutive morbidly obese
patients (72% women; mean (SD) age 42 (12) years) who
attended our tertiary care center between December 2005
and February 2007 were examined by a multidisciplinary
team and offered surgical or conservative treatment. The
chi-square test, independent samples t test, and multiple
logistic regression were used in the statistical analyses.
Results A total of 249 (49%) patients underwent bariatric
surgery. When compared to the conservative group of
patients, the surgery group was characterized by a signifi-
cantly higher mean (SD)BMI(46.5(6.2)vs.43.2(5.5) kg/m
2,
p<0.001), earlier onset of obesity (40% vs. 26% before
12 years of age, p<0.001), and lower age (41(11) vs. 44
(13) years, p=0.002). In contrast, the groups did not differ
significantly with respect to gender or obesity-related
comorbidities. After adjustments for gender, age, onset of
obesity, and the number of comorbidities, multiple regres-
sion revealed that patients with BMI 40–50 or >50 kg/m
2
had between 3 (OR=3.0; 95% CI 1.9–4.9, p<0.001) and 6
(OR=5.7; 95% CI 3.0–11.0, p<0.001) times the chance of
undergoing bariatric surgery when compared to patients
with a BMI <40 kg/m
2 (reference).
Conclusion Our data indicates that increasing BMI rather
than obesity-related comorbidities, predicted treatment
choice in morbidly obese patients.
Keywords Obesity.Morbid.Therapy.Bariatricsurgery.
Comorbidity
Introduction
The prevalence of obesity is increasing worldwide [1]a n d
Norway is no exception; currently 20% of the population is
obese (BMI ≥30 kg/m
2)[ 2]. Morbid obesity (BMI ≥40 kg/m
2
or BMI ≥35 kg/m
2 with at least one obesity-related
comorbidity) is associated with both increased susceptibility
to a wide range of diseases and increasing mortality rates [3].
Long-termfollow-upstudieshavedemonstratedthebeneficial
effects that bariatric surgery can have on obesity-related
comorbidities, quality of life and survival [3–6]. Although
conservative treatment is less effective than bariatric surgery
in terms of weight reduction, several studies have shown the
significant and durable effects which behavioral therapy,
lifestyle changes, low-calorie diets, and pharmacotherapy
can have on weight loss, weight maintenance [7–10], type 2
diabetes, and quality of life [11, 12].
The indications for bariatric surgery are widely accepted
[13–15]. Morbidly obese patients who have attempted to
lose weight by nonoperative means and who are well
informed and motivated may be considered for surgery. The
patient should be evaluated by a multidisciplinary team and
the surgeon should have substantial experience in a clinical
setting with adequate support. Lifelong medical surveil-
lance is necessary to both support adherence to mandatory
behavioral changes and to prevent micronutrient and
vitamin deficiencies after surgical therapy. Only a small
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surgery, and given this the criteria for selection is of the
upmostimportance.Dixonhasrecentlyarguedthatthereferral
of patients with a BMI >50 kg/m
2, or with a BMI >40 kg/m
2
with a serious weight loss responsive comorbidity for a
surgical opinion, should not be merely an option but a
physician`s responsibility as best care for the patients [16].
The primary objective of this study was to examine
whether the variables that influence treatment choice (level
of obesity, age, weight history, and obesity-related comorbid-
ities) differ between morbidly obese patients undergoing
bariatric surgery and those opting for conservative treatment.
Methods
Study Design
This was a cross-sectional observational cohort study of
consecutive treatment seeking morbidly obese patients
attending the Morbid Obesity Center (MOC). Patients
who underwent bariatric surgery (surgery group, SG) were
compared with patients who received conservative therapy
(conservative treatment group, CTG).
Setting
The Public Healthcare System and Patient Rights
The Norwegian healthcare system is public and usually free
of charge for individual patients. In 2004, the Ministry of
Health and Care Services acknowledged morbid obesity as
an increasingly serious public health problem and instructed
the five Regional Health Authorities (RHAs) to provide
morbidly obese patients with an appropriate treatment
choice; either conservative or surgical. Recently released
national guidelines conclude that treatment seeking mor-
bidly obese subjects shall be offered a complete diagnostic
workup and startup of therapy, either conservative or
surgical, in an obesity clinic based on the multidisciplinary
team model [17].
The Morbid Obesity Center
The MOC is a tertiary care center founded by the South-
Eastern Norway RHA, which itself serves close to one
million inhabitants in the southern part of Norway. The
MOC has implemented the national guidelines referred
to above.
Physicians at local hospitals may refer morbidly obese
patients who have undergone repeated trials of unsuccessful
weight loss. All patients who are referred to the MOC
undergo a thorough (up to 6 months) assessment by a
multidisciplinary team consisting of an internist, a dietician,
a physiotherapist, and a trained “obesity” nurse. During the
first visit, the internist establishes a detailed medical
history, checks previous diagnostic workups, performs a
physical examination, and briefly informs the patient of
further investigations and treatment alternatives. At the
second visit the doctor reiterates this message, providing
complete information about the possible risks and benefits
of an operation and also encouraging the patient to
incorporate their own values and preferences in the
decision-making process. If no contraindication against
surgery exists the patient and the physician together agree
upon the most appropriate choice of therapy; either surgical
or conservative. We perform approximately 200 bariatric
operations a year and 90% of these procedures are
laparoscopic gastric bypasses. Patients who do not undergo
surgery are offered a variety of individual or group-based
conservative treatment options, either in our outpatient
clinic or at various weight loss camps. These centers have
implemented motivation guidance techniques in order to
provide a comprehensive intervention program which will
increase physical activity and fitness, normalize eating
habits and induce a weight loss of at least 5–10% during the
first year.
Data from the first consultation at the MOC was extracted
from a prospective database on 524 patients enrolled
consecutively between November 2005 and February 2007.
In order to be included in the database all patients gave
written informed consent. All patient records were reviewed
within 21–36 months after the first consultation at the MOC
in order to assess treatment choice.
Participants
A total of 524 patients attended the MOC during the
inclusion period (Fig. 1). After excluding 13 patients with
a BMI <35 kg/m
2 and six patients (1%) with unknown
treatment choice, 505 patients were included in the
analysis. At a median (range) of 28 (21–36) months after
the first consultation a total of 249 patients (49%) had
undergone surgery, while 256 patients (51%) had been
treated conservatively. A small number of patients (8/511)
were refused surgery due to either old age (n=2), their
lack of ability to cooperate (n=2), the increased operative
risk caused by previous abdominal surgery or serious
comorbidity (n=6), or a combination of increased
operative risk and comorbidity which was not likely to
improve after bariatric surgery (n=3). These patients
accepted the doctor’s decision and were included in the
conservative treatment group. One patient was advised by
the doctor to try conservative treatment, but decided to
have surgery at a private clinic. This patient was included
in the surgery group.
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Type 2 diabetes was diagnosed in patients who had either a
prior history of type 2 diabetes or a fasting serum glucose
level ≥7.0 mmol/l [18]. Patients with previously diagnosed
hypertensionandpatientswithbloodpressure≥140/90mmHg
were categorized as having hypertension. Dyslipidemia was
defined as elevated fasting triglycerides (≥1.7 mmol/l)
and/or reduced HDL-cholesterol (<1.0 mmol/l in men
and <1.3 mmol/l in women). Age at onset of obesity was
recorded as either before 12 years, between 12 and
20 years, or after the age of 20.
Physical Examination
Patients, wearing light clothing and no shoes, were
measured for weight and height and BMI subsequently
calculated (kg/m
2). Waist circumference was measured at
the level midway between the lowest rib margin and the
iliac crest. Hip circumference was measured and waist/hip
ratio calculated. After at least 5 min rest and while seated in
an upright position, blood pressure was measured with an
appropriately sized cuff. Three measurements were made and
the average of the second and third was used in the analyses.
Statistical Methods
Data are given as either mean (SD), median, or proportions
unless otherwise stated. Differences between groups were
analyzed using independent samples t test (continuous data)
and #
2 (categorical data). Multiple logistic regression with
predefined explanatory variables was used to assess whether a
patient would opt for bariatric surgery or not (yes/no). Hosmer
Lemeshowtestwasusedtoassesstheadequacyofthefitofthe
logistic regression models. We fitted five separate logistic
regression models. First (model 1; unadjusted), BMI was
entered as a categorical variable (level 0=<40 kg/m
2 [refer-
ence], level 1=40–50 kg/m
2, and level 2=≥50 kg/m
2)i na
univariate logistic regression analysis with bariatric surgery
(yes/no) as the dependent variable. Second (model 2), the
effect of BMI was adjusted for gender and age in a multiple
logistic regression analysis. Third (model 3) onset of obesity
categorized as <12 years, 12–20 years, or >20 years
(reference), was added to model 2. Fourth (model 4), the
number of obesity-related comorbidities (type 2 diabetes,
yes = 1, no = 0; hypertension, yes = 1, no = 0; obstructive
sleep apnea, yes = 1, no = 0; dyslipidemia, yes = 1, no = 0;
and joint pain; yes = 1, no = 0) were added to model 3 as a
continuous variable. Finally, type 2 diabetes (yes/no) replaced
numberofcomorbiditiesinmodel4(model5).A5%statistical
significancelevelwaschosen.Theanalyseswereimplemented
using SPSS 16.0 (SPSS, Chicago, IL, USA).
Results
Demographic and clinical characteristics from the first
consultation are shown in Table 1.
Age
Patients in the SG were on average 3 years younger than
patients in the CTG. The proportion of patients, within
various age groups, offered surgery or conservative
treatment is shown in Fig. 2. In addition, patients in the
surgery group were characterized by a lower age at onset of
obesity (Fig. 3): 40% were obese before the age of 12
compared to 26% in the conservative group (p=0.001).
Body Weight
On average, the SG had a 9 kg higher body weight than the
CTG (Table 1). Approximately one quarter of the patients
with BMI <40 kg/m
2 underwent bariatric surgery, as did half
of the patients with a BMI of 40–50 kg/m
2 and more than
two thirds of the patients with a BMI >50 kg/m
2 (Fig. 4).
Among patients with a BMI <40 kg/m
2 the proportion
with type 2 diabetes who underwent surgery was
significantly higher than those who were nondiabetic
(36% vs. 24%, p=0.031). By contrast, diabetic status
was not a significant variable in the explanation of the
treatment choices made by patients with BMI >40 kg/m
2
(data not shown).
Fig. 1 Flowchart of patients and treatment choice
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Table 2 shows that the two treatment groups were
comparable with respect to the prevalence of coronary
heart disease, type 2 diabetes, hypertension, obstructive
sleep apnea, current smoking, pulmonary disease, and
medication. Notably, the prevalence of type 2 diabetes
was 23% in both groups, while the proportion of patients
using various number of antidiabetic drugs did not differ
significantly between groups. Similarly, approximately half
the patients within both groups had hypertension, with the
usage of antihypertensive drugs not differing significantly.
Logistic Regression Analyses—Odds for Having Surgery
In both the univariate (1) and multiple logistic regression
models (2–5) increasing BMI levels were associated with
significantly higher odds for having surgery (Table 3).
When compared to those patients with a BMI <40 kg/m
2
(reference), those with either a BMI between 40 and 50 or a
BMI above 50 kg/m
2 were three to six times more likely to
undergo bariatric surgery, even after adjustments for gender,
age, age at onset of obesity, and the number of weight-
related comorbidities.
Furthermore, the full model (model 4) shows that both
lower age and age at onset of obesity <12 years were
associated with higher odds for surgery. Each yearly
increase in age was associated with a 4% less chance of a
patient opting for surgery. A history of childhood obesity
was associated with a 61% increased odds for surgery
(adulthood obesity reference). Male patients tended to opt
for surgery less than females (OR 0.68, 95% CI 0.45–1.03).
As illustrated in model 4 and 5, neither the number of
weight-related comorbidities nor the presence of type 2
diabetes predicted treatment choice.
Discussion
The major finding from our study of a population of
treatment seeking morbidly obese patients is that increasing
levels of BMI, early onset of obesity and younger age, rather
than obesity-related comorbidities, were associated with the
increased likelihood of a patient opting for bariatric surgery.
Fig. 3 Age at onset of obesity. Distribution of the patients in the
surgery group (SG) and the conservative treatment group (CTG)
according to age at onset of obesity. The chi-square test was used for
statistical analysis
Fig. 2 Age. Distribution of the patients in the surgery group (SG) and
the conservative treatment group (CTG) according to age The chi-
square test was used for statistical analysis
SG (n=249) CTG (n=256) p value
Female 180 (72%) 173 (68%) 0.304
Age (years) 41 (11) 44 (13) 0.002
BMI (kg/m
2) 46.5 (6.2) 43.2 (5.5) <0.001
Body weight (kg) 136 (23.2; range 90–226) 127 (20.5; range 82–200) <0.001
Waist circumference (cm) 136 (15) 131 (14) <0.001
Hip circumference (cm) 137 (12) 133 (15) <0.001
Waist-to-hip ratio 1.00 (0.10) 1.00 (0.10) 0.696
Maximum weight (kg) 143 (24) 134 (23) <0.001
Max weight, age (years) 38 (11) 41 (14) 0.057
Previous bariatric surgery 11 (4%) 5 (2%) 0.135
Table 1 Demographic and clin-
ical characteristics
Data are means (SD) for con-
tinuous variables and n (%) for
categorical variables
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It is well known that obesity-related comorbidities such as
type 2 diabetes and obstructive sleep apnea either improve or
resolve after bariatric surgery. As such, the existence of any
serious obesity-related comorbidity in a morbidly obese
patient supports surgery as an appropriate treatment choice.
In light of this, we were surprised by the overall absence of a
relationship between obesity-related comorbidities and treat-
ment choice (except among patients with a BMI <40 kg/m
2 in
which surgery was more often chosen by patients with type 2
diabetes than those without diabetes). This finding might
have several explanations. First, although several lines of
evidence indicate that laparoscopic bariatric surgery is
associated with low death and complication rates, surgery
still is a serious intervention that can be fatal. Accordingly,
concerns about surgical complications might have favored a
conservative treatment choice among patients with serious
comorbidities. Second, all patients who receive conservative
treatment are informed that surgery might be an option later
on if the conservative approach fails. Thus, patients initially
choosing a conservative treatment strategy might request
bariatric surgery in the future. Third, our tertiary care clinic
offers a variety of conservative treatment strategies including
individual or group-based behavioral therapy programs,
either in our outpatient clinic or at weight loss camps, which
might have been attractive despite previous treatment failures.
Fourth, until very recently, official diabetes guidelines have
not acknowledgedthattype2 diabetesmay beone ofthe most
important indications for bariatric surgery. However, the latest
guidelines fromboththe NorwegianDirectorate ofHealthand
the American Diabetes Association (2009) recommend that
“Bariatric surgery should be considered for adults with a
BMI≥35kg/m
2 and type 2 diabetes, especially if the diabetes
is difficult to control with lifestyle and pharmacologic
therapy” [19]. In light of this we will thoroughly reassess
and scrutinize our routines to ensure that all patients receive
balanced and updated information concerning the beneficial
effects of bariatric surgery on type 2 diabetes. Finally,
differences in quality of life [20] and internalized prejudices
against surgical treatment of a “lifestyle-induced” disease
might have influenced the choice of therapy.
Weight Significantly Affected the Likelihood of a Patient
Opting for Surgery
IthasrecentlybeenarguedthatpatientswithaBMI>50kg/m
2,
and particularly patients with a BMI >50 kg/m
2 and type 2
diabetes, should be referred to bariatric surgery as “best
practice” [16] and as a “standard treatment option” [21]. Our
results partly concur with these suggestions to the extent that
they show that patients with a BMI >50 kg/m
2 were six times
more likely to have surgery than those with a BMI between
3 5a n d4 0k g / m
2. Approximately, one quarter of patients with
a BMI <40 underwent bariatric surgery, as did half the
patients with a BMI between 40 and 50 and more than two
thirds of the patients with a BMI greater than 50 kg/m
2.
Fig. 4 BMI. Proportion of patients within each BMI category who
underwent surgery (SG) or received conservative treatment (CTG).
The chi-square test was used for statistical analysis
Table 2 Comorbidities and drug therapy according to treatment
choice
SG
(n=249)
CTG
(n=256)
p value
Type 2 diabetes 57 (23%) 58 (23%) 1.000
Antidiabetic drugs 44 (18%) 36 (14%) 0.332
No. of drugs
1 25 (10%) 16 (6%) 0.388
≥2 19 (8%) 21 (8%)
Hypertension 127 (51%) 136 (53%) 0.698
Antihypertensive drugs 79 (32%) 89 (35%) 0.529
No of drugs
1 34 (14%) 41 (16%)
2 25 (10%) 27 (11%) 0.877
≥3 20 (8%) 21 (8%)
Obstructive sleep apnoea 36 (15%) 45 (18%) 0.404
Asthma 55 (22%) 52 (20%) 0.704
COPD 9 (4%) 9 (4%) 1.000
Asthma and/or COPD 62 (25%) 58 (23%) 0.626
Asthma and COPD (drugs) 53 (21%) 45 (18%) 0.347
Joint pain 155 (62%) 150 (59%) 0.454
Pain killers 70 (28%) 57 (22%) 0.158
Hyperlipidemia 180 (72%) 168 (66%) 0.128
Statins 27 (11%) 32 (13%) 0.659
Anxiety/depression 88 (35%) 102 (40%) 0.314
Coronary heart disease 10 (4%) 16 (6%) 0.350
Current smoking 74 (30%) 66 (25%) 0.484
Data are n (%)
COPD chronic obstructive pulmonary disease
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Another factor to be considered when prioritizing patients
for bariatric surgery is age. There has been partial
agreement, but also much debate, about an upper age-
limit for bariatric surgery [22, 23]. The current European
guidelines suggest that “bariatric surgery above age
60 years should be considered on an individual basis”.
Our study can be seen to have cohered with these guidelines
given that only a small proportion (3%) of the patients in the
surgery group were above 60 years of age. The majority of
patients >60 years received conservative treatment.
Strengths and Limitations
The validity of our findings is strengthened by the fact that
they emerged from the prospective collection and registra-
tion of data from a relatively large population of treatment
seeking morbidly obese individuals. In addition, the
associations between explanatory variables and treatment
choice remained robust even after adjustments for relevant
confounding variables.
Our study had several limitations. First, the cross-sectional
design made it impossible to establish a cause–effect
relationship. Second, our results may not be valid in non-
white populations. Third, we cannot exclude the possibility
that referral of patients to a tertiary care center might have
introduced a sampling bias limiting the generalizability of our
results. Fourth, although our multidisciplinary team aims to
provide the patients with objective and balanced information
about the various treatment alternatives, we cannot exclude
the possibility of selection bias.
Finally, we have not addressed psychological factors
which also may influence the choice of treatment. However,
a recent Swedish study of patients choosing between
surgery and conservative treatment showed there to be no
significant differences in psychological disturbances [24].
Conclusion
Our results indicate that increasing levels of BMI rather than
obesity-related comorbidities, predicted treatment choice in
morbidly obese patients. To our knowledge this is the first
study to address the effect of somatic comorbidities on the
treatment choices of morbidly obese patients. As such, our
findings should be validated by others.
Funding Gunn Signe Jakobsen has received an unrestricted educa-
tional grant from Vestfold Hospital Trust. Dag Hofsø has received
unrestricted educational grants from Novo Nordisk A/S, South-Eastern
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